Asston Pharmaceuticals share news, announcements and annual reports
BSE: 544445Pharmaceuticals & BiotechnologySmall Cap
ASSTON PHARMACEUTICALS LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2025
Last close ₹150.70up ₹4.45 (3.04%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹146.25.
29 Oct: open ₹151.39, high ₹151.39, low ₹143.11
52-week range of traded prices to 29 Oct 2026
₹60.00Low, 21 Jul 2026₹151.39High, 29 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹165 Cr3,188th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 318.39
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.35 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 42.59
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 1.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.35 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 9.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 31,000
Asston Pharmaceuticals share news and announcements
84 announcements, routine notices left out, newest first. Page 2 of 2.
Jan 2026
29 Jan · Board meeting
Meeting on 7 Feb 2026: increase in authorised capital29 Jan · Management
29 Jan · Management
21 Jan · Commencement Of Commercial Production
5 Jan · Announcement under Regulation 30 (LODR)-Meeting Updates
5 Jan · Board meeting
2 Jan · Board meeting
Meeting on 5 Jan 2026
Nov 2025
14 Nov · Regulation 30 SEBI (LODR) Regulation Update.
11 Nov · Board meeting
Meeting on 14 Nov 2025: half yearly results
Oct 2025
16 Oct · General Announcement
16 Oct · Meeting Updates
16 Oct · Board meeting
13 Oct · Board meeting
Meeting on 16 Oct 20251 Oct · Announcement under Regulation 30 (LODR)-Meeting Updates
Sep 2025
2 Sep · Business
Aug 2025
25 Aug · Pursuant To The Provisions Of Regulation 42 Of SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015
25 Aug · Board meeting
21 Aug · Board meeting
Meeting on 25 Aug 2025: annual general meeting
Jul 2025
31 Jul · Business
16 Jul · Listing of Equity Shares of Asston Pharmaceuticals Ltd
Trading Members of the Exchange are hereby informed that effective from July 16, 2025, the equity shares of Asston Pharmaceuticals Ltd (Scrip Code: 544445) are listed and admitted to dealings ....